Biomarker ID | 1204 |
PMID | 23984644 |
Year | 2013 |
Biomarker | hsa-mir-31; hsa-mir-145; hsa-mir-455; hsa-mir-221; hsa-mir-222; hsa-mir-143; hsa-mir-221; hsa-mir-133b; hsa-mir-376c; hsa-mir-187; hsa-mir-139; hsa-mir-455; hsa-mir-224; hsa-mir-204; hsa-mir-505; hsa-mir-149; hsa-mir-222; hsa-mir-34a; hsa-mir-152; hsa-mir-30e; hsa-mir-377; hsa-mir-181c; |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in PCa (log Fold Change): [] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Cancer Vs Benign |
Type of Biomarker | Diagnostic |
Cohort | The accession number of expression profile is GSE36802, containing 21 paired samples from prostate cancer tissue and benign prostate tissue. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p < 0.0401 |
Method Used | Affymetrix miRNA Array |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | hsa-mir-31, hsa-mir-145, hsa-mir-455, hsa-mir-221, hsa-mir-222, hsa-mir-143, hsa-mir-221, hsa-mir-133b, hsa-mir-376c, hsa-mir-187, hsa-mir-139, hsa-mir-455, hsa-mir-224, hsa-mir-204, hsa-mir-505, hsa-mir-149, hsa-mir-222, hsa-mir-34a, hsa-mir-152, hsa-mir-30e, hsa-mir-377, hsa-mir-181c |